Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer

Article Abstract:

An immunohistochemical method for the determination of RRM1 expression in tumors and two other proteins relevant to non-small-cell lung cancer, the excision repair cross-complementation group 1 (ERCC1) protein and the phosphatase and tensin homologue (PTEN), is presented. Results demonstrate that RRM1 and ERCC1 are determinants of survival after surgical treatment of early-stage, non-small-cell lung cancer.

Author: Bepler, Gerold, Haura, Eric, Zhong Zheng, Tingan Chen, Xueli Li, Sharma, Anupama
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
United States, Disease/Disorder overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


EGFR mutation and resistance of non-small-cell lung cancer to Gefitinib

Article Abstract:

The gefitinib and erlotinic that target the epidermal growth factor receptor (EGFR) pathway show promising results in the treatment of metastatic non-small-cell lung cancer. The response rates to these drugs are 10 to 20 percent when these ATP-competitive anilinoquinazoline inhibitors are used as second-or- third-line treatment for advanced disease.

Author: Janne, Pasi A., Eck, Michael J., Tenen, Daniel G., Kobayashi, Susumu, Boggon, Titus J., Dayaram, Tajhal, Kocher, Olivier, Meyerson, Matthew, Johnson, Bruce E., Halmos, Balazs
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
United Kingdom, Epidermal growth factor receptors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission

Article Abstract:

Radiotherapy to the head may lower the chance that small-cell lung cancer will spread to the brain. Data on 987 patients in remission from small-cell lung cancer show that those who received cranial irradiation were more likely to be alive three years later. Cranial irradiation also increased the likelihood that they would survive without a relapse.

Author: Wagner, Henry, Arriagada, Rodrigo, Aisner, Joseph, Pignon, Jean-Pierre, Johnson, Bruce E., Auperin, Anne, Le Pechoux, Cecile, Gregor, Anna, Stephens, Richard J., Kristjansen, Paul E.G., Ueoka, Hiroshi
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
Evaluation, Prevention, Development and progression, Radiotherapy, Metastasis, Cancer metastasis, Brain cancer, Lung cancer, Small cell, Small cell lung cancer

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Diagnosis, Lung cancer, Non-small cell, Non-small cell lung cancer
Similar abstracts:
  • Abstracts: Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
  • Abstracts: Mass immunisation: for and against. Rubella and the MMR vaccine. Measles, mumps and rubella-safety of the combined vaccine
  • Abstracts: Angiotensin-converting-enzyme inhibition in stable coronary artery disease. Preventing microalbuminuria in type 2 diabetes
  • Abstracts: Management of cervical adenocarcinoma in situ during pregnancy. Successful surgical treatment of a primary liver gastrinoma during pregnancy: A case report
  • Abstracts: Geriatrics and the limits of modern medicine. Early androgen deprivation for prostate cancer? Risk of fracture after androgen deprivation for prostate cancer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.